Review of the CANTOS Trial

Review of the CANTOS Trial

Up next

Summary and discussion of SAFE-T and RACE II

For full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe 

Summary and discussion of AFFIRM and RACE

For full review of the trials, please visit https://cardiologytrials.substack.com/ Get full access to Cardiology Trial’s Substack at cardiologytrials.substack.com/subscribe 

Recommended Episodes

Eagle’s Eye View: Inflammation and Cholesterol are Predictors of CV Events
Eagle's Eye View: Your Weekly CV Update From ACC.org

In this week's View, Dr. Eagle looks at a collaborative analysis of three randomized trials that investigated inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy. He then covers the 2023 ACC Expert Consensus Decision Pathway ...  Show more

Eagle’s Eye View: What is the Association of Cardiac Damage on Health Status Both Before and After AVR?
Eagle's Eye View: Your Weekly CV Update From ACC.org

In this week’s View, Dr. Eagle discusses Lp(a) as a main driver for the risk of ASCVD, MI, and aortic valve stenosis independent of CRP. This article is timely as we continue to attempt to lower the risks with ongoing trials currently working on relevant therapeutic options for l ...  Show more

Eagle’s Eye View: What are the cardiovascular outcomes with clopidogrel versus aspirin?
Eagle's Eye View: Your Weekly CV Update From ACC.org

 In this week’s View, Dr. Eagle discusses the value of the balloon pulmonary angioplasty procedure for patients with chronic thromboembolic pulmonary hypertension. He then reviews the sub analysis of the HOST EXAM trial assessing the benefit of aspirin versus clopidogrel as a mai ...  Show more

Association Between Transcatheter Aortic Valve Replacement and Early Postprocedural Stroke
Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Dr. Venu Menon, Director of the Cardiovascular Fellowship Program and Section Head, Clinical Cardiology and Chetan Huded MD, Interventional Fellow discuss incidence of stroke up to 30 days after TAVR. Dr. Huded published his findings in JAMA . Drs. Menon and Huded discuss the pat ...  Show more